{"protocolSection":{"identificationModule":{"nctId":"NCT02505295","orgStudyIdInfo":{"id":"1421"},"organization":{"fullName":"Mazandaran University of Medical Sciences","class":"OTHER"},"briefTitle":"Selenium and Ischemic Stroke Outcome","officialTitle":"Evaluation of Selenium Supplementation in Ischemic Stroke Outcome"},"statusModule":{"statusVerifiedDate":"2020-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-01","type":"ACTUAL"},"completionDateStruct":{"date":"2018-01","type":"ACTUAL"},"studyFirstSubmitDate":"2015-07-11","studyFirstSubmitQcDate":"2015-07-21","studyFirstPostDateStruct":{"date":"2015-07-22","type":"ESTIMATED"},"lastUpdateSubmitDate":"2020-01-22","lastUpdatePostDateStruct":{"date":"2020-01-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Athena Sharifi Razavi","investigatorTitle":"Assistant professor","investigatorAffiliation":"Mazandaran University of Medical Sciences"},"leadSponsor":{"name":"Mazandaran University of Medical Sciences","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Selenium is a trace element essential to human health.Selenium protection against cellular damage by oxygen radicals is accomplished through selenoproteins. Ischemic stroke is associated with the generation of oxygen free radicals resulting in a condition of oxidative stress. Supplementing stroke patients with antioxidant nutrients may improve survival."},"conditionsModule":{"conditions":["Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"This study is a feasibility/pilot study","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":44,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"selenium","type":"ACTIVE_COMPARATOR","description":"vial selenium (selenase 500 microgr ) 2000 microgram stat and 1000 microgram daily for 5 days","interventionNames":["Dietary Supplement: Selenium"]},{"label":"normal saline","type":"PLACEBO_COMPARATOR","description":"40 cc normal saline stat and 20 cc daily for 5 days( in vials like selenase vial)","interventionNames":["Drug: normal saline"]}],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Selenium","description":"4 vials selenase stat and 2 vials daily for 5 days","armGroupLabels":["selenium"],"otherNames":["selenase","Selenium selenite"]},{"type":"DRUG","name":"normal saline","description":"Normal saline infusion like intervention group","armGroupLabels":["normal saline"],"otherNames":["Sodium chloride 0.9%"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"National Institutes of Health Stroke Scale(NIHSS)","description":"The primary outcome of interest in this study was defined as at least 25% reduction in NIHSS score in day 7 or at the discharge in selenium group compared with control; as an indicator of short term outcome.","timeFrame":"up to 3 days"},{"measure":"modified Rankin Scale (MRS)","description":"The primary outcome of interest in this study was defined as at least 1 point reduction in mRS score in day 7 or at the discharge in selenium group compared with control; as an indicator of short term outcome.","timeFrame":"at day 5-8"}],"secondaryOutcomes":[{"measure":"Barthel index","description":"The secondary outcome defined as Barthel index \\>75 three months after stroke, which indicates assisted independence, for long term outcome evaluation and comparison of mortality rate during the study follow-up between groups.","timeFrame":"3 months after discharge"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Accepted ischemic stroke by brain CT or MRI during last 72 h\n2. Ischemic stroke in Middle Cerebral Artery territory\n3. Volume of stroke at list one third of MCA territory\n4. written informed consent.\n\nExclusion Criteria:\n\n1. Known allergy to selenium\n2. Severe renal failure( cr clearance under 50 ml/min or serum cr upper than 2\n3. Severe hepatic failure( total bill upper than 2 or ALT/AST 5 time upper than normal limit)\n4. Severe neurodegenerative disease such as severe dementia, alzheimer and Parkinson\n5. Pregnancy or lactation","healthyVolunteers":true,"sex":"ALL","minimumAge":"20 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"athena sharifi razavi, MD","affiliation":"assistant professor in neurology","role":"STUDY_CHAIR"}],"locations":[{"facility":"Athena Sharifi Razavi","city":"Sari","state":"Mazandaran","zip":"4818777111","country":"Iran, Islamic Republic of","geoPoint":{"lat":36.56332,"lon":53.06009}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000012643","term":"Selenium"}],"ancestors":[{"id":"D000000975","term":"Antioxidants"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000014131","term":"Trace Elements"},{"id":"D000018977","term":"Micronutrients"}],"browseLeaves":[{"id":"M15145","name":"Selenium","asFound":"Lamivudine","relevance":"HIGH"},{"id":"M19888","name":"Sodium Selenite","relevance":"LOW"},{"id":"M3982","name":"Antioxidants","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"M20699","name":"Micronutrients","relevance":"LOW"},{"id":"M16575","name":"Trace Elements","relevance":"LOW"}],"browseBranches":[{"abbrev":"Micro","name":"Micronutrients"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}